1. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. (December 2018) Authors: Bensch, Frederike; van der Veen, Elly; Lub-de Hooge, Marjolijn; Jorritsma-Smit, Annelies; Boellaard, Ronald; Kok, Iris; Oosting, Sjoukje; Schröder, Carolina; Hiltermann, T.; van der Wekken, Anthonie; Groen, Harry; Kwee, Thomas; Elias, Sjoerd; Gietema, Jourik; Bohorquez, Sandra; Crespigny, Alex; W... Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. Issue 17 (10th June 2021) Authors: Ho, Alan L.; Brana, Irene; Haddad, Robert; Bauman, Jessica; Bible, Keith; Oosting, Sjoukje; Wong, Deborah J.; Ahn, Myung-Ju; Boni, Valentina; Even, Caroline; Fayette, Jerome; Flor, Maria José; Harrington, Kevin; Kim, Sung-Bae; Licitra, Lisa; Nixon, Ioanna; Saba, Nabil F.; Hackenberg, Stephan; Spe... Journal: Journal of clinical oncology Issue: Volume 39:Issue 17(2021) Page Start: 1856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗